Lantern Pharma, Inc. (LTRN)
2.71
+0.03
(+1.12%)
USD |
NASDAQ |
Mar 03, 16:00
2.74
+0.03
(+1.11%)
After-Hours: 20:00
Lantern Pharma Free Cash Flow : -16.86M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -99.27M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
| Imunon, Inc. | -14.95M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.572M |
| Cash from Investing (Quarterly) | 5.928M |
| Cash from Financing (Quarterly) | 0.9718M |
| Free Cash Flow Per Share (Quarterly) | -0.4221 |
| Free Cash Flow to Equity (Quarterly) | -4.522M |
| Free Cash Flow to Firm (Quarterly) | -4.573M |
| Free Cash Flow Yield | -57.63% |